MEI Pharma will be getting $20 million in near-term cash and potentially hundreds millions more under a new cancer drug partnership with Swedish company Helsinn Group. In the deal, MEI Pharma’s pracinostat will be licensed to Helsinn Group under an exclusive worldwide agreement to develop and commercialize the drug for acute myeloid leukemia and possibly … Continue reading “MEI Pharma Just Landed A Huge Million Dollar Deal”
